These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29143287)

  • 1. Lipoic Acid Stimulates cAMP Production in Healthy Control and Secondary Progressive MS Subjects.
    Fiedler SE; Yadav V; Kerns AR; Tsang C; Markwardt S; Kim E; Spain R; Bourdette D; Salinthone S
    Mol Neurobiol; 2018 Jul; 55(7):6037-6049. PubMed ID: 29143287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lipoic acid on walking performance, gait, and balance in secondary progressive multiple sclerosis.
    Loy BD; Fling BW; Horak FB; Bourdette DN; Spain RI
    Complement Ther Med; 2018 Dec; 41():169-174. PubMed ID: 30477834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling.
    Salinthone S; Yadav V; Schillace RV; Bourdette DN; Carr DW
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20927401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoic acid modulates inflammatory responses of monocytes and monocyte-derived macrophages from healthy and relapsing-remitting multiple sclerosis patients.
    Fiedler SE; Spain RI; Kim E; Salinthone S
    Immunol Cell Biol; 2021 Jan; 99(1):107-115. PubMed ID: 32762092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
    Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
    Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoic acid stimulates cAMP production via G protein-coupled receptor-dependent and -independent mechanisms.
    Salinthone S; Schillace RV; Tsang C; Regan JW; Bourdette DN; Carr DW
    J Nutr Biochem; 2011 Jul; 22(7):681-90. PubMed ID: 21036588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal Tolerability and Absorption of R- Versus R,S-Lipoic Acid in Progressive Multiple Sclerosis: A Randomized Crossover Trial.
    Cameron M; Taylor C; Lapidus J; Ramsey K; Koop D; Spain R
    J Clin Pharmacol; 2020 Aug; 60(8):1099-1106. PubMed ID: 32212340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lipoic acid on migration of human B cells and monocyte-enriched peripheral blood mononuclear cells in relapsing remitting multiple sclerosis.
    George JD; Kim E; Spain R; Bourdette D; Salinthone S
    J Neuroimmunol; 2018 Feb; 315():24-27. PubMed ID: 29306401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of cytotoxic Eomes-expressing CD4
    Raveney BJE; Sato W; Takewaki D; Zhang C; Kanazawa T; Lin Y; Okamoto T; Araki M; Kimura Y; Sato N; Sano T; Saito Y; Oki S; Yamamura T
    Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoic acid stimulates cAMP production in T lymphocytes and NK cells.
    Schillace RV; Pisenti N; Pattamanuch N; Galligan S; Marracci GH; Bourdette DN; Carr DW
    Biochem Biophys Res Commun; 2007 Mar; 354(1):259-64. PubMed ID: 17210133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
    Bellenberg B; Schneider R; Weiler F; Suchan B; Haghikia A; Hoffjan S; Gold R; Köster O; Lukas C
    Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis.
    Muris AH; Rolf L; Broen K; Hupperts R; Damoiseaux J; Smolders J
    J Steroid Biochem Mol Biol; 2016 Nov; 164():254-257. PubMed ID: 26598277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of endogenous antiradical protective system in multiple sclerosis.
    Davitashvili D; Beridze M; Shakarishvili R; Kiziria M; Sanikidze T
    Georgian Med News; 2012 Apr; (205):11-9. PubMed ID: 22665726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.
    Huber AK; Wang L; Han P; Zhang X; Ekholm S; Srinivasan A; Irani DN; Segal BM
    Neurology; 2014 Oct; 83(17):1500-7. PubMed ID: 25253754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble thrombomodulin levels in plasma of multiple sclerosis patients and their implication.
    Festoff BW; Li C; Woodhams B; Lynch S
    J Neurol Sci; 2012 Dec; 323(1-2):61-5. PubMed ID: 22967748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis.
    Frisullo G; Nociti V; Iorio R; Patanella AK; Marti A; Caggiula M; Mirabella M; Tonali PA; Batocchi AP
    Cytokine; 2008 Oct; 44(1):22-5. PubMed ID: 18793860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoic acid stimulates cAMP production via the EP2 and EP4 prostanoid receptors and inhibits IFN gamma synthesis and cellular cytotoxicity in NK cells.
    Salinthone S; Schillace RV; Marracci GH; Bourdette DN; Carr DW
    J Neuroimmunol; 2008 Aug; 199(1-2):46-55. PubMed ID: 18562016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sera from remitting and secondary progressive multiple sclerosis patients disrupt the blood-brain barrier.
    Shimizu F; Tasaki A; Sano Y; Ju M; Nishihara H; Oishi M; Koga M; Kawai M; Kanda T
    PLoS One; 2014; 9(3):e92872. PubMed ID: 24686948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of IL-10 and IL-12p40 in secondary progressive multiple sclerosis.
    Soldan SS; Alvarez Retuerto AI; Sicotte NL; Voskuhl RR
    J Neuroimmunol; 2004 Jan; 146(1-2):209-15. PubMed ID: 14698865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.